About US
Contact us
-
Mylan enters settlement agreement with Pfizer for Caduet Tablets litigationMylan Inc. (Nasdaq: MYL) today announced that it has entered into a settlement agreement with Pfizer Inc. resolving litigation related to Caduet® Tablets, 2.5 mg/10, 2.5 mg/20 mg, 2.5 mg/40 mg, 52011/1/25
-
Sanofi-aventis acquires world-wide license for ADC productsOxford BioTherapeutics (OBT) today announces that sanofi-aventis has acquired an exclusive world-wide license to one of OBT's internal preclinical antibody programs. sanofi-aventis intends to use t2011/1/25
-
China Shenghuo's Lixuwang product recieves Chinese Well-Known Trademark HonorChina Shenghuo Pharmaceutical Holdings, Inc., a China-based pharmaceutical company engaged in the research, development, manufacture, and marketing of Traditional Chinese Medicine (TCM), nutritional s2011/1/24
-
Bayer's gadobutrol injection for CNS imaging receives FDA Advisory Committee approvalBayer HealthCare Pharmaceuticals Inc. announced today that the Peripheral and Central Nervous System Drugs Advisory Committee to the U.S. Food and Drug Administration (FDA) voted unanimously that clin2011/1/24
-
GSK, Valeant receive European CHMP positive opinion for TrobaltGlaxoSmithKline (GSK) and Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) h2011/1/23
-
Merck and Lead Discovery to Develop Anti-Cancer CompoundsMerck Serono, a division of Merck, has announced a cooperation agreement with the Lead Discovery Center (LDC), a small molecule drug discovery spin-off of Max Planck Innovation, to promote the discove2011/1/23
-
Novo Nordisk to appeal against ruling in repaglinide combination patent caseToday, Novo Nordisk announced that Judge Avern Cohn of the US District Court for the Eastern District of Michigan issued an adverse ruling in a patent litigation case regarding Novo Nordisk's US Paten2011/1/21
-
Huanggang Winner receives State Development and Reform Commission's Cotton Processing CertificateWinner Medical Group Inc. a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today announced that one of its2011/1/21
-
Regeneron and Bayer Begin Retinal Disease Drug StudyRegeneron and Bayer HealthCare have initiated a Phase III clinical to evaluate the efficacy and safety of VEGF Trap-Eye (aflibercept ophthalmic solution) in patients with myopic choroidal neovasculari2011/1/20
-
Merck Serono and Domain to Develop Parkinson's DrugsMerck Serono and Domain Therapeutics have entered into a development and licensing agreement to develop positive allosteric modulators of metabotropic glutamate receptor 4 to treat for Parkinson's dis2011/1/20